Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03109158
Title NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors NanoCarrier Co., Ltd.
Indications

head and neck squamous cell carcinoma

Therapies

Cetuximab + Fluorouracil + NC-6004

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.